23andMe Archives -

Personalised and tailored healthcare that utilises patient’s data is rapidly becoming a reality. Ben Hargreaves looks at the

Digital health: the new normal?

https://pharmaphorum.com/digital/digital-health-the-new-normal/

Consumer DNA testing company 23andMe has signed a deal to acquire privately-held Lemonaid Health in a $400 million

23andMe makes $400m telehealth play, gulping down Lemonaid

https://pharmaphorum.com/news/23andme-makes-400m-telehealth-play-gulping-down-lemonaid/

DNA testing company 23andMe has signed a deal to merge with a ‘blank cheque’ company set up by

23andMe goes public using Richard Branson’s blank cheque company

https://pharmaphorum.com/news/23andme-goes-public-using-richard-bransons-blank-cheque-company/

Doctolib, the largest digital health service in Europe, has raised 150 million euros in a funding round, valuing

France’s Doctolib is new digital health unicorn

https://pharmaphorum.com/news/frances-doctolib-is-new-digital-health-unicorn/

The FDA will allow consumer DNA testing company 23andMe to give customers reports on their risk of hereditary

FDA approves consumer colorectal cancer test

https://pharmaphorum.com/news/fda-approves-consumer-colorectal-cancer-test/

Service can now be marketed as test for Alheimer’s and Parkinson’s, among others.

FDA approval for 23andMe’s direct-to-consumer genetics test

https://pharmaphorum.com/news/fda-approval-23andmes-direct-consumer-genetics-test/

23andMe